Yuichi Iwaki
2022
In 2022, Yuichi Iwaki earned a total compensation of $1.3M as President and Chief Executive Officer at MediciNova, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,579 |
|---|---|
| Option Awards | $359,594 |
| Salary | $620,167 |
| Other | $18,300 |
| Total | $1,292,640 |
Iwaki received $620.2K in salary, accounting for 48% of the total pay in 2022.
Iwaki also received $294.6K in non-equity incentive plan, $359.6K in option awards and $18.3K in other compensation.
Rankings
In 2022, Yuichi Iwaki's compensation ranked 2,537th out of 5,760 executives tracked by ExecPay. In other words, Iwaki earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,537 out of 5,760 | 56th |
Division Manufacturing | 1,400 out of 3,136 | 55th |
Major group Chemicals And Allied Products | 636 out of 1,422 | 55th |
Industry group Drugs | 590 out of 1,323 | 55th |
Industry Pharmaceutical Preparations | 423 out of 969 | 56th |
Source: SEC filing on April 26, 2023.
Iwaki's colleagues
We found two more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2022.